Latest oncology News

AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases
Threading Together Stories Of Hope
Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours
OMP and PwC Alliance Moves Process Manufacturers from Siloed Supply Chain Planning to Unified Decisions
Aiming to improve care of patients with endocrine tumours
Enhertu recommended for approval in the EU by CHMP as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive…
Seeking to understand how childhood cancer tumours arise and grow
Enhertu demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in…
People affected by cancer need a stronger voice in shaping Generative AI for oncology
Enhertu plus pertuzumab approved in the EU as first new regimen in more than a decade for the 1st-line treatment of patients…
Lung cancer patient became tumour-free after treatment with selenite
De-stress And Expand Your Brain At NeuroSTEM
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival as 1st-line treatment of patients with HER2-mutant advanced non-small cell lung…
Breakthrough may change treatment for metastatic prostate cancer
Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner
Enhertu plus pertuzumab recommended for approval in the EU by CHMP as 1st-line treatment for patients with HER2-positive metastatic breast cancer
Two KI researchers receive innovation funding from Knut and Alice Wallenberg Foundation
Release Of IHACPA Work Program 2026-27
Sitting for long stretches linked to a higher risk of death from cancer – oncologist answers questions about the new study
Major Day Oncology Expansion At Epworth Geelong
Love Your Sister funding helping big data project crack the code of kids’ cancer
How Amy Knott found her future in nursing at Southern Cross University
‘Phins up’ as aviators train with league team
From Italy to KI – Paolo wants to contribute to future cancer treatments
New funding for KI researchers working on childhood cancer
Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive metastatic solid tumours
Local volunteers recognised at Greater Shepparton Volunteer Recognition Awards
Enhertu approved in the US for two new indications for patients with HER2-positive early breast cancer
Leader inducted to Tasmanian Nurses and Midwives Honour Roll
Cairns Gastrointestinal Cancer Nurse Appointed
Pay rise on the way for thousands of workers
Common genetic marker may guide new treatment for acute leukaemia
Bundaberg Colorectal Cancer Nurse Appointed
Major milestone as new brain treatment technology arrives
Drug developer acquires potential cancer treatment discovered by QIMR Berghofer researcher
Professor Daniel Galvão appointed to lead PCFA Research Advisory Committee
Thousands of Tassie workers to get pay rise
New First Nations Cancer Care Nurse For Gold Coast
New treatment reduces recurrence and improves survival in bladder cancer
Consultation open on IHACPA’s draft Work Program 2026-27
North Shore Gastrointestinal Cancer Nurse Appointed
First prize at the EAU Congress for study on efficient prostate cancer testing
Construction complete for Orange Health Service palliative care expansion
NSW new construction complete for Orange Health Service palliative care expansion
Uncovering a key signaling pathway linking liver cancer and fibrosis
Unusual tumor cells may be overlooked factors in advanced breast cancer
Enhertu granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
Exercise Is New Black